glp-1 for mental health The Impact of Receptor Agonists (GLP-1 RAs) on Health: A Systematic Review | Current Treatment Options in Psychiatry An analysis on the role

In contrast, GLP-1RAs are designed to resist degradation by DPP-4, enabling sustained high plasma concentrations and prolonged systemic effects

Integrative Potential and Clinical Insight From a functional medicine perspective, GLP-1, GLP-2, and VIP peptides could become adjunctive supports in MCAS and related conditions such as IBS, POTS, EhlersDanlos syndrome, chronic fatigue, and long COVID, where mast-celldriven neuroinflammation plays a central role

In clinical trials, the 25 mg daily dose of oral Wegovy resulted in an average weight loss of 16.6%, comparable to the injectable version

Ensure you maintain adequate nutrition and do not avoid entire food groups due to taste disturbances